WHO expressed concern over the deaths of children due to cough syrup, asking – Was it exported to other countries?

WHO officials have asked the Indian government whether these dangerous syrups have been exported abroad. If so, WHO will consider issuing a Global Medical Products Alert.

The news of 25 children dying in India after drinking cough syrup has shaken everyone. People are shocked by the loss of innocent children's lives, and questions are being raised about how safe these cough syrups are. The World Health Organization (WHO) has now taken action. The WHO has asked the Indian government whether the cough syrups that caused the children's deaths have been exported to other countries. It should be noted that several children have died in Madhya Pradesh and Rajasthan after drinking a cough syrup called Coldrif.

This thing was found in syrup.

Investigations revealed that the syrup contained excessive amounts of two chemicals, Diethylene Glycol (DG) and Ethylene Glycol (EG). Both chemicals proved extremely dangerous for children. In Madhya Pradesh, 22 children died from this syrup, while five are in critical condition. Three children have also died from this syrup in various districts of Rajasthan. These incidents have drawn the attention of not only the local administration but also international organizations.

WHO asked this question?

The WHO has also taken action in this matter. WHO officials have asked the Indian government whether these dangerous syrups have been exported abroad. If so, the WHO will consider issuing a Global Medical Products Alert. Such an alert is issued when a defect is found in a drug or product that could pose a threat to public health. If these syrups have been exported to other countries, the WHO may soon issue an advisory to prevent similar incidents in other countries.

This incident raised many questions.

In India, this issue has raised questions about the pharmaceutical industry and regulatory bodies. The Drugs Controller General of India (DCGI) has issued strict instructions to all states and union territories. In a letter, the DCGI stated that any drug must be thoroughly tested before being released to the market. Deficiencies have been found in some areas, which the DCGI has expressed displeasure about. It has ordered all pharmaceutical companies to rigorously inspect every batch before releasing it to the market for sale. 

The situation is worse in Chhindwara.

The highest number of deaths in this case occurred in the Chhindwara district of Madhya Pradesh. The local administration has also taken strict action. The owner of the pharmaceutical company that manufactured this syrup has been arrested. Investigations have also revealed that chemicals like DG and EG present in the syrup proved toxic to children. These chemicals are not common ingredients used in cough syrups and can be fatal in high doses.